CpG island methylation results in the silencing of the associated gene and is an important step in tumorigenesis. Following a comprehensive isolation of CpG islands that were methylated in human lung adenocarcinoma, we found that in cancer cells de novo CpG island methylation generally occurred in a sporadic manner. However, some methylated CpG islands appeared to cluster in discrete chromosomal regions. In this study, we have investigated the methylation status of CpG islands located at such chromosomal loci. We have found that many CpG islands at the HOXA and HOXD loci were methylated in human lung adenocarcinoma. The de novo methylation of these CpG islands was also observed in patient's DNA from noncancerous portions of lung tissue. These results indicate the presence of speci®c chromosomal regions that are susceptible to de novo methylation.
CpG island methylation results in the silencing of the associated gene and is an important step in tumorigenesis. Following a comprehensive isolation of CpG islands that were methylated in human lung adenocarcinoma, we found that in cancer cells de novo CpG island methylation generally occurred in a sporadic manner. However, some methylated CpG islands appeared to cluster in discrete chromosomal regions. In this study, we have investigated the methylation status of CpG islands located at such chromosomal loci. We have found that many CpG islands at the HOXA and HOXD loci were methylated in human lung adenocarcinoma. The de novo methylation of these CpG islands was also observed in patient's DNA from noncancerous portions of lung tissue. These results indicate the presence of speci®c chromosomal regions that are susceptible to de novo methylation. Oncogene (2002) 21, 3659 ± 3662. DOI: 10.1038/sj/ onc/1205453 Keywords: CpG island; DNA methylation; HOX gene CpG island methylation is an important epigenetic process in carcinogenesis that results in the inactivation of the associated gene . We have reported the comprehensive isolation of CpG islands methylated in human lung adenocarcinomas (Shiraishi et al., 2002) . Although there was no apparent clustering of methylated CpG islands to speci®c chromosomes, a number of CpG islands were located in close proximity to each other (Shiraishi et al., 2002) . It is not known whether de novo methylation such as CpG island methylation in cancer is regulated for each single gene or at a larger domain level. Therefore to address this issue we have investigated whether methylated CpG islands cluster in human lung cancer DNA.
Methylation status was analysed by methyl-CpG binding domain (MBD) column chromatography (Shiraishi et al., 1999) . We have previously reported that DNA fragments associated with nonmethylated CpG islands are eluted at low salt fractions (L), while those associated with methylated ones are eluted at high salt fractions (H) (Shiraishi et al., 1999) . Representative results are shown in Figure 1 and Table 1 . The methylation status of 11 CpG islands from the HOXA gene cluster (spanning 120 kb of the short arm of chromosome 7) were analysed by MBD column chromatography and PCR ( Figure 1a ). In seven of the eight patients the CpG island of the HOXA4 gene was methylated in tumor DNA and also in DNA from the noncancerous portion of lung (Figure 1 ). The CpG island of the HOXA7 gene was methylated in seven of the eight tumors, but methylation of DNA from a noncancerous portion of lung was only observed in patient 59 (Figure 1 ). Clustering of methylated CpG islands was also detected following analysis of the methylation status of seven CpG islands in the HOXD gene cluster on the long arm of chromosome 2. The HOXD11 CpG island was methylated in four of eight tumors and also methylated in DNA from the noncancerous portion of lung in three of the eight patients (Figure 1 ). The HOXD13 CpG island was methylated in seven of eight tumors, but methylation in DNA from a noncancerous portion of the lung was only observed in patient 108 ( Figure 1 ). All the analysed CpG islands in HOXA and HOXD loci were methylated in multiple tumor DNA.
We also investigated the methylation status of CpG islands at other chromosomal loci. CpG islands B1035 (exon 1A of the PAX6 gene) and B1260 are located 5 kb apart on chromosome 11 and speci®cally methylated in tumors in many patients (Figure 1b ). However the CpG island that contains exon 1B of the PAX6 gene, which is 4 kb from CpG island B1035, was only methylated in one patient ( Figure 1b) . The CpG island of the nearby RCN1 gene was unmethylated in all patients. CpG islands B453 and that of the VE-JAM gene, located approximately 900-kb apart on chromosome 21, were methylated in tumors ( Figure  1b ), however the CpG islands of nearby PRED22 and GABPA genes were unmethylated in all eight patients. The CpG island of the ADAMTS1 gene was methylated in only one patient. A similar phenomenon was also observed when a region on chromosome 22 was analysed (data not shown). Collectively these results suggest that in cancer cells CpG island methylation occurs largely in a sporadic manner but Oncogene (2002) 
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there are also a number of chromosomal regions where methylated CpG islands are densely clustered. Methylation of CpG islands at these loci was also evident in DNA from noncancerous portions of the lung, however we were unsure of the cause and signi®cance of de novo methylation of CpG islands in noncancerous portions of lung tissue. This may represent an event associated with aging (Issa et al., 1994; Ahuja et al., 1998) or remnant of increased DNA methyltransferase activity in precursor cells.
Despite the sporadic occurrence of CpG island methylation, regional clustering of CpG islands was observed in several areas including the HOXA and HOXD loci. Moreover, aberrant methylation was not tumor-speci®c and also observed in DNA derived from noncancerous portions of lung tissue. We con®rmed that CpG islands in HOXA and HOXD loci are all methylation-free in normal somatic tissue DNA (MaN, Figure 1 and data not shown) Furthermore, methylation of each CpG island in noncancerous portions of Figure 1 Analysis of the methylation status of CpG islands in speci®c chromosomal regions. (a) MBD column chromatography and PCR analysis of CpG islands associated with four HOX genes. Tsp509 I digests of genomic DNAs were fractionated as described previously (Shiraishi et al., 1999) . PCR primers used in the experiments are shown in Table 1 . PCR primers were designed to enable detection of the corresponding Tsp509 I fragment. Symbols L and H indicate low and high salt fractions, respectively. Detection of PCR products in L but not in H indicates nonmethylation. Detection of PCR products in H indicates methylation. Numerical characters refer to respective patients. C and N indicate DNA from cancerous lung tissue or that from noncancerous lung tissue, respectively. MaN, DNA from normal submandibular glands. (b) Methylation status of CpG islands. Open and closed circles indicate absence and presence of methylated allele(s), respectively, as revealed by the presence of PCR products in H. The presence of faint bands in H was also included after reproducibility of the result was con®rmed by repeated PCR experiments. Sizes below the vertical bars indicate approximate distance between CpG islands at either end of the loci. The relative order of each CpG island was arranged on the basis of published nucleotide sequence (not to scale) the lung did not occur in all patients. These results suggest that methylation of these CpG islands is not an intrinsic, developmentally programmed event, but a de novo event.
Although HOX genes are developmentally regulated they are also expressed in somatic tissues, suggesting that their gene products play some roles in dierentiated cells. It has been reported that a minority of the genes continue to be expressed in adult lung tissue (Tiberio et al., 1994; Kappen, 1996; Calvo et al., 2000; Golpon et al., 2001; Lechner et al., 2001) . The HOXA5 gene product positively regulates the expression of the In order to increase PCR eciency and speci®city during ampli®cation, 1 M betaine (Henke et al., 1997) was added. b Algorithm available at website http://www.ebi.ac.uk/cpg/ was used to detect potential CpG islands TP53 gene and the gene is inactivated by CpG island methylation (Raman et al., 2000) . Furthermore, it is also reported that HOXA10 gene product binds to the promoter region of the CDKN1A gene, which is a target of the TP53 gene product, and activates its transcription in dierentiating myelomonocytic cells (Bromleigh and Freedman, 2000) . These results suggest that the inactivation of these genes has tumorsuppressive eects in appropriate cells.
The relationship between HOX gene silencing and CpG island methylation is complex. It has been demonstrated that methylation of the CpG island of the HOXA5 gene results in silencing (Raman et al., 2000) . In contrast, it has been reported that some expressed genes are located in a methylated region at HOXB loci in human small cell lung cancer (Flagiello et al., 1996) . It may be possible that methylation is not a sole determinant for silencing of HOX genes. Another possible explanation is that, since the methylation analysis in earlier studies was performed on the basis of sensitivity to digestion with restriction endonucleases, the apparent methylation may only re¯ect methylation status of such sites and not be a representative of the entire region.
Our study demonstrated the presence of chromosomal regions that are susceptible to de novo methylation. We can speculate that these regions, or HOX genes themselves, are susceptible to de novo methylation due to their chromatin structure or alternatively they are a preferred substrate for DNA methyltransferase(s)-mediated de novo methylation. Histone modi®cation may also mediate methylation (Fuks et al., 2000; Rountree et al., 2000; Robertson et al., 2000; Tamaru and Selker, 2001) . It is also reported that some mouse Hox genes are de novo methylated in certain tissues in the course of development (Razin and Kafri, 1994) , although this methylation seems to be a programmed event. It would also appear that dysregulation of methylation possibly occurs at an early stage of the carcinogenesis process and those genes that are inactivated by methylation are candidate tumor suppressor genes. Further characterization of such regions will elucidate how de novo methylation occurs, spreads and is maintained in cancer cells.
